ANTX
AN2 Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.05
+3.06%Sep 16, 2026, 21:33 UTC
AN2 Therapeutics granted inducement equity awards to its newly-appointed Chief Medical Officer Cameron Trenor, consisting of a non-qualified stock option for 233,333 shares and restricted stock units representing 116,6 shares.
Source:Sep 16, 2026, 21:33 UTC
AN2 Therapeutics appointed Cameron Trenor, M.D. as its new Chief Medical Officer.
Source: